+52.8%
SNOW vs MRNA
+153.9%
-101.1%
-56.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.1% | -2.2% | -3.0% | -5.0% |
| 7D | -12.4% | -12.7% | +0.3% | -11.9% |
| 30D | -21.0% | -20.7% | -0.4% | -20.3% |
| 3M | -20.7% | +46.3% | -67.0% | -22.0% |
| 6M | +52.6% | +305.2% | -252.6% | +35.6% |
| YTD | +16.2% | +561.2% | -545.1% | -5.2% |
| 1Y | +4.2% | +772.1% | -767.9% | -19.0% |
| 3Y | +52.8% | +147.0% | -94.1% | +42.3% |
| All | +52.8% | +153.9% | -101.1% | +42.3% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling